Raffles Medical Group Ltd
RAFLF
$0.8073
$0.05737.64%
OTC PK
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 12.35M | 11.91M | 11.85M | 11.98M | 11.32M |
| Total Depreciation and Amortization | 7.98M | 7.70M | 8.26M | 8.35M | 7.35M |
| Total Amortization of Deferred Charges | 504.70K | 486.50K | 438.10K | 443.00K | -- |
| Total Other Non-Cash Items | -19.20K | -18.50K | 1.07M | 1.09M | -256.00K |
| Change in Net Operating Assets | 950.90K | 916.70K | -2.24M | -2.26M | -5.64M |
| Cash from Operations | 21.77M | 20.99M | 19.39M | 19.60M | 12.77M |
| Capital Expenditure | -1.09M | -1.06M | -2.85M | -2.88M | -4.31M |
| Sale of Property, Plant, and Equipment | -- | -- | 800.00 | 800.00 | 400.10K |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 1.04M | 1.01M | 1.62M | 1.64M | 1.47M |
| Cash from Investing | -49.60K | -47.80K | -1.23M | -1.24M | -2.44M |
| Total Debt Issued | 644.50K | 644.50K | 6.76M | 6.76M | 27.07M |
| Total Debt Repaid | -5.08M | -5.08M | -16.15M | -16.15M | -30.35M |
| Issuance of Common Stock | 208.00K | 208.00K | 14.50K | 14.50K | 125.50K |
| Repurchase of Common Stock | -3.76M | -3.76M | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -17.80M | -17.16M | 0.00 | 0.00 | -16.47M |
| Other Financing Activities | -1.07M | -1.07M | -1.23M | -1.23M | -2.07M |
| Cash from Financing | -24.77M | -23.88M | -7.95M | -8.04M | -20.32M |
| Foreign Exchange rate Adjustments | -603.90K | -582.20K | 68.60K | 69.40K | 283.30K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -3.65M | -3.52M | 10.28M | 10.39M | -9.71M |